Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9049 - 9056 of 11616 results
U.S. Department of Labor Re-Proposes Rules Governing the Definition of “Fiduciary”: Part 1: The Rule and its Exceptions
May 14, 2015| Blog| Viewpoint
Motion to Sever Denied as Opt Out Alternative by Judge Swain of the Southern District of New York
May 14, 2015| Blog| Viewpoint
More Biosimilar Q&A’s Released by FDA
May 14, 2015| Blog| Viewpoint
CMS Changes Medicare Prescriber Enrollment Requirements
May 14, 2015| Blog| Viewpoint
PTAB Clarifies Protocol for Expanded Post-Grant Panels
May 13, 2015| Blog| Viewpoint
EPA’s Proposed Nano Rule: What Should You Be Doing Now?
May 13, 2015| Blog| Viewpoint
Class Action Recovery - A Changing Landscape
May 13, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.